The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Cost-effectiveness of pembrolizumab in second-line advanced bladder cancer.

Michal  Sarfaty

No Relationships to Disclose

Peter  Hall

Consulting or Advisory Role - Pfizer (Inst); Roche (Inst)

Research Funding - Sysmex (Inst)

Kelvin K.  Chan

No Relationships to Disclose

Kiran  Virik

No Relationships to Disclose

Moshe  Leshno

No Relationships to Disclose

Noa  Gordon

No Relationships to Disclose

Assaf  Moore

No Relationships to Disclose

Victoria  Neiman

No Relationships to Disclose

Eli  Rosenbaum

No Relationships to Disclose

Daniel A.  Goldstein

Stock and Other Ownership Interests  - TailorMed

Honoraria - AstraZeneca